Link to the full article: www.farmacista33.it/politica-sanitaria/30299/revisione-della-pharma-legislation-equilibrio-tra-innovazione-e-accesso.html
Related reading
Shaping the Future of Cancer Care: All.Can Hosts High-Level Event at the European Parliament
Brussels, 3 June 2026 — Sharp thinking, genuine engagement, and a topic deserving of every bit of energy in the room defined All.Can International’s high-level event held Tuesday 2 June, at the European Parliament and online.
From Volume to Value: All.Can International at the Cancer Mission Fair in Nicosia
On 28 April 2026, All.Can International Executive Director Madalina Iamandei took to the stage at the Cancer Mission Fair in Nicosia, Cyprus, to deliver a Mission Spark intervention on the future of cancer care across Europe.
Person-centred care and bladder cancer: All.Can speaks at the EUrology Policy Forum Croatia
During Bladder Cancer Awareness Month, All.Can International’s Executive Director contributed a video statement to the EUrology Policy Forum Croatia, making the case for efficiency and person-centred approaches across the full bladder cancer care pathway.